Confirmatory Trials for Drugs Approved on a Single Trial.

Haslam, Alyson; Prasad, Vinay

Haslam, Alyson; Prasad, Vinay.

Affiliation

Haslam A; Division of Hematology Oncology, Knight Cancer Institute (A.H., V.P.).
Prasad V; Division of Hematology Oncology, Knight Cancer Institute (A.H., V.P.).

Circ Cardiovasc Qual Outcomes ; 12(6): e005494, 2019 06.

Article in En | MEDLINE | ID: mdl-31137954

Subject(s)

Aminobutyrates/therapeutic use; Angiotensin II Type 1 Receptor Blockers/therapeutic use; Cardiovascular Diseases/prevention & control; Clinical Trials as Topic; Dietary Supplements; Drug Approval; Eicosapentaenoic Acid/analogs & derivatives; Heart Failure/drug therapy; Protease Inhibitors/therapeutic use; Research Design; Tetrazoles/therapeutic use; Aminobutyrates/adverse effects; Angiotensin II Type 1 Receptor Blockers/adverse effects; Biphenyl Compounds; Cardiovascular Diseases/diagnosis; Cardiovascular Diseases/epidemiology; Dietary Supplements/adverse effects; Drug Combinations; Eicosapentaenoic Acid/adverse effects; Eicosapentaenoic Acid/therapeutic use; Evidence-Based Medicine; Heart Failure/diagnosis; Heart Failure/mortality; Heart Failure/physiopathology; Humans; Neprilysin/antagonists & inhibitors; Protease Inhibitors/adverse effects; Tetrazoles/adverse effects; Treatment Outcome; Valsartan

Key words

bias clinical trials; drug approval; fish oils; valsartan

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Protease Inhibitors / Research Design / Tetrazoles / Cardiovascular Diseases / Eicosapentaenoic Acid / Clinical Trials as Topic / Drug Approval / Dietary Supplements / Angiotensin II Type 1 Receptor Blockers / Aminobutyrates Type of study: Diagnostic_studies Language: En Journal: Circ Cardiovasc Qual Outcomes Year: 2019 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google